Literature DB >> 34997422

Typical and atypical phenotype and neuroimaging of X-linked adrenoleukodystrophy in a Chinese cohort.

Chenhui Mao1, Jie Li1, Xinying Huang1, Jie Wang1, Shanshan Chu1, Yao Zhang1, Liling Dong1, Caiyan Liu1, Lin Lu2, Ling Qiu3, Wei Chen4, Bin Peng1, Liying Cui1, Jing Gao5.   

Abstract

OBJECTIVE: The objective of this study is to describe the typical and atypical clinical and neuroimaging features of ALD in Chinese patients, which will help early diagnosis and intervention to improve prognosis of ALD.
METHODS: Forty-one patients in the Leukoencephalopathy Clinic of Neurology Department, Peking Union Medical College Hospital were enrolled. Detailed clinical manifestations and MRI features were analyzed. The relationship between phenotype and genotype as well as biochemical analysis was observed.
RESULTS: The patients were classified according to phenotype and onset age, including 14 childhood cerebral ALD (CCALD), 8 adolescent cerebral ALD (adoCALD), 3 adult cerebral ALD (ACALD), 14 adrenomyeloneuropathy (AMN), and 2 ALD in women. AMN was the main presentation in adults. Visual impairment was usual onset symptom in CCALD and cognitive decline and psychiatric symptoms were found in adoCALD and ACALD. Typical MRI feature of CALD was symmetrical peri-ventricular "butterfly wings" like lesions in frontal and/or occipital lobe with peripheral DWI hyperintensities and Gd enhancement. Corpus callosum and internal capsule were always involved. Unilateral lesions were also possible. Cerebral AMN presented with centrum semiovale diffuse involvement. Spinocerebellar variant was a special subtype of AMN with obvious cerebellar and brainstem lesions. No relationships between phenotype and genotype as well as biochemical VLCFAs analysis were found.
CONCLUSIONS: We emphasize that corpus callosum and internal capsule are always involved in ALD. A unilateral lesion is also possible. Neuroimaging of cerebral AMN is different from typical CALD with more centrum semiovale involvement. We support spinocerebellar variant was a rare subtype of AMN.
© 2022. Fondazione Società Italiana di Neurologia.

Entities:  

Keywords:  Adrenomyeloneuropathy; Genotype; Phenotype; Spinocerebellar variant; X-linked adrenoleukodystrophy

Mesh:

Year:  2022        PMID: 34997422     DOI: 10.1007/s10072-021-05859-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.830


  26 in total

Review 1.  General aspects and neuropathology of X-linked adrenoleukodystrophy.

Authors:  Isidro Ferrer; Patrick Aubourg; Aurora Pujol
Journal:  Brain Pathol       Date:  2010-07       Impact factor: 6.508

Review 2.  Biochemical aspects of X-linked adrenoleukodystrophy.

Authors:  Stephan Kemp; Ronald Wanders
Journal:  Brain Pathol       Date:  2010-07       Impact factor: 6.508

Review 3.  Early Onset Primary Adrenal Insufficiency in Males with Adrenoleukodystrophy: Case Series and Literature Review.

Authors:  Liane Eng; Molly O Regelmann
Journal:  J Pediatr       Date:  2019-05-14       Impact factor: 4.406

4.  Long-term outcome of patients with X-linked adrenoleukodystrophy: A retrospective cohort study.

Authors:  Christel Tran; Jaina Patel; Hewson Stacy; Eva G Mamak; Hanna Faghfoury; Julian Raiman; Joe T R Clarke; Susan Blaser; Saadet Mercimek-Mahmutoglu
Journal:  Eur J Paediatr Neurol       Date:  2017-02-21       Impact factor: 3.140

Review 5.  X-linked adrenoleukodystrophy: pathogenesis and treatment.

Authors:  Marc Engelen; Stephan Kemp; Bwee-Tien Poll-The
Journal:  Curr Neurol Neurosci Rep       Date:  2014-10       Impact factor: 5.081

Review 6.  X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects.

Authors:  Stephan Kemp; Johannes Berger; Patrick Aubourg
Journal:  Biochim Biophys Acta       Date:  2012-03-28

7.  Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy.

Authors:  Florian Eichler; Christine Duncan; Patricia L Musolino; Paul J Orchard; Satiro De Oliveira; Adrian J Thrasher; Myriam Armant; Colleen Dansereau; Troy C Lund; Weston P Miller; Gerald V Raymond; Raman Sankar; Ami J Shah; Caroline Sevin; H Bobby Gaspar; Paul Gissen; Hernan Amartino; Drago Bratkovic; Nicholas J C Smith; Asif M Paker; Esther Shamir; Tara O'Meara; David Davidson; Patrick Aubourg; David A Williams
Journal:  N Engl J Med       Date:  2017-10-04       Impact factor: 91.245

8.  X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management.

Authors:  Marc Engelen; Stephan Kemp; Marianne de Visser; Björn M van Geel; Ronald J A Wanders; Patrick Aubourg; Bwee Tien Poll-The
Journal:  Orphanet J Rare Dis       Date:  2012-08-13       Impact factor: 4.123

9.  MRI brain lesions in asymptomatic boys with X-linked adrenoleukodystrophy.

Authors:  Afonso P Liberato; Eric J Mallack; Razina Aziz-Bose; Doug Hayden; Arne Lauer; Paul A Caruso; Patricia L Musolino; Florian S Eichler
Journal:  Neurology       Date:  2019-03-22       Impact factor: 11.800

10.  Clinical characteristics and phenotype distribution in 10 Chinese patients with X-linked adrenoleukodystrophy.

Authors:  Ming-Rui Jia; Wen-Zhen Wu; Chuan-Ming Li; Xiao-Hui Cai; Lin Zhang; Fang Yan; Chan Zhu; Ming-Hong Gu
Journal:  Exp Ther Med       Date:  2019-07-24       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.